These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2754393)

  • 1. Tumor necrosis factor identified in multiple sclerosis brain.
    Hofman FM; Hinton DR; Johnson K; Merrill JE
    J Exp Med; 1989 Aug; 170(2):607-12. PubMed ID: 2754393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain.
    Hofman FM; von Hanwehr RI; Dinarello CA; Mizel SB; Hinton D; Merrill JE
    J Immunol; 1986 May; 136(9):3239-45. PubMed ID: 3082983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis.
    Hofman FM; Hinton DR; Baemayr J; Weil M; Merrill JE
    Clin Immunol Immunopathol; 1991 Mar; 58(3):331-42. PubMed ID: 1900461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue.
    Smolders J; Schuurman KG; van Strien ME; Melief J; Hendrickx D; Hol EM; van Eden C; Luchetti S; Huitinga I
    J Neuropathol Exp Neurol; 2013 Feb; 72(2):91-105. PubMed ID: 23334593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical investigation of human leukocyte antigen (HLA)-DR-positive astrocytes in adrenoleukodystrophy brain.
    Katsuragi T; Iseki E; Kosaka K; Nishimura T; Akiyama H; Ikeda K; Kato M
    Neurosci Lett; 1996 Nov; 219(3):207-10. PubMed ID: 8971816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune response in multiple sclerosis plaques.
    Boyle EA; McGeer PL
    Am J Pathol; 1990 Sep; 137(3):575-84. PubMed ID: 1698025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions.
    van Noort JM; Bsibsi M; Gerritsen WH; van der Valk P; Bajramovic JJ; Steinman L; Amor S
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):694-703. PubMed ID: 20535035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin induced expression of interleukin-1 alpha, tumor necrosis factor-alpha, and transforming growth factor-alpha in cultured astrocytes.
    DeVito WJ; Avakian C; Stone S; Okulicz WC; Tang KT; Shamgochian M
    J Cell Biochem; 1995 Feb; 57(2):290-8. PubMed ID: 7759566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.
    Selmaj K; Raine CS; Cannella B; Brosnan CF
    J Clin Invest; 1991 Mar; 87(3):949-54. PubMed ID: 1999503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte interactions with immune modifiers: a possible role for astrocytes in the immunopathogenesis of multiple sclerosis (MS).
    Barna BP; Chou SM; Ransohoff RM; Jacobs B
    Prog Clin Biol Res; 1984; 146():153-7. PubMed ID: 6718422
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cytokines in MS lesion].
    Kato H; Suzumura A
    Nihon Rinsho; 2003 Aug; 61(8):1428-34. PubMed ID: 12962034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha in the retina in acquired immune deficiency syndrome.
    Hofman FM; Hinton DR
    Invest Ophthalmol Vis Sci; 1992 May; 33(6):1829-35. PubMed ID: 1582785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens.
    Hayashi T; Morimoto C; Burks JS; Kerr C; Hauser SL
    Ann Neurol; 1988 Oct; 24(4):523-31. PubMed ID: 3266456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.
    Liedtke W; Cannella B; Mazzaccaro RJ; Clements JM; Miller KM; Wucherpfennig KW; Gearing AJ; Raine CS
    Ann Neurol; 1998 Jul; 44(1):35-46. PubMed ID: 9667591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1b is expressed in multiple sclerosis lesions.
    Battistini L; Fischer FR; Raine CS; Brosnan CF
    J Neuroimmunol; 1996 Jul; 67(2):145-51. PubMed ID: 8765339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and immunoregulatory molecules in malignant glial neoplasms.
    Schneider J; Hofman FM; Apuzzo ML; Hinton DR
    J Neurosurg; 1992 Aug; 77(2):265-73. PubMed ID: 1625016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis.
    Morcos Y; Lee SM; Levin MC
    Mult Scler; 2003 Aug; 9(4):332-41. PubMed ID: 12926837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.